http://orcid.org/0000-0003-2229-1200
Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Laura Cucinella, Lara Tiranini, Chiara Cassani, Silvia Martella & Rossella E Nappi. (2023) Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Current Perspectives on the Role of Laser Therapy. International Journal of Women's Health 15, pages 1261-1282.
Read now
Read now
Rossella E. Nappi, Nicholas Panay, Santiago Palacios, Vivek Banerji, Genevieve Hall, Martire Particco & Dan Atkins. (2023) Using advanced analytics to help identify women who are more likely to have a severe subjective experience of vulvovaginal atrophy: a modeling study. Gynecological Endocrinology 39:1.
Read now
Read now
Haixiao Wen, Chong Lu, Meng Zhang & Xingling Qi. (2023) A real-world disproportionality analysis of ospemifene: data mining of the public version of FDA adverse event reporting system. Expert Opinion on Drug Safety 22:11, pages 1133-1142.
Read now
Read now
R. Sánchez-Borrego, M. V. de Diego Pérez de Zabalza, M. J. Alfageme Gullón, M. L. Alija Castrillo, M. Sánchez Prieto, S. Palacios, A. J. González Calvo, J. J. Quijano Martín & M. J. Cancelo. (2023) Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA. Climacteric 26:5, pages 437-444.
Read now
Read now
R. E. Nappi, L. Tiranini, E. Martini, D. Bosoni, C. Cassani & L. Cucinella. (2023) Different local estrogen therapies for a tailored approach to GSM. Climacteric 26:4, pages 361-366.
Read now
Read now
S. Palacios, R. E. Nappi, M. J. Cancelo, S. Sánchez & T. Simoncini. (2023) Expert opinion on the treatment of vulvovaginal atrophy with ospemifene based on new evidence. Climacteric 26:4, pages 388-391.
Read now
Read now
Gilbert G.G. Donders & Francesca H.W.V. Donders. (2023) New developments in the management of vulvovaginal atrophy: a comprehensive overview. Expert Opinion on Pharmacotherapy 24:5, pages 599-616.
Read now
Read now
S. Palacios, M. Ramirez & M. Lilue. (2022) Efficacy of low-dose vaginal 17β-estradiol versus vaginal promestriene for vulvovaginal atrophy. Climacteric 25:4, pages 383-387.
Read now
Read now
Aino Fianu Jonasson & Mikael Åstrom. (2021) An Open, Uncontrolled Pilot Study on 12-Week Use of VagiVital for Treatment of Vulvovaginal Atrophy in Breast Cancer Patients Undergoing Adjuvant Aromatase-Inhibitor Therapy. Medical Devices: Evidence and Research 14, pages 193-200.
Read now
Read now
X. Ruan, L. Zhang, Y. Cui, M. Gu & A. O. Mueck. (2021) Genitourinary syndrome of menopause in Chinese perimenopausal and postmenopausal women. Climacteric 24:3, pages 297-304.
Read now
Read now
L. M. Pompei, M. C. O. Wender, N. R. de Melo, J. Kulak$suffix/text()$suffix/text(), D. Pardini, R. B. Machado, C. E. Fernandes, S. Palacios & R. E. Nappi. (2021) Vaginal Health: Insights, Views & Attitudes survey in Latin America (VIVA-LATAM): focus on Brazil. Climacteric 24:2, pages 157-163.
Read now
Read now
Rossella E. Nappi, Maurizio Guida, Diego Marchesoni, Antonio Cianci, Antonio Pellegrino, Valentino Remorgida, Tiziana Di Paolantonio & Pierluigi Benedetti Panici. (2021) Vulvovaginal atrophy of menopause and its impact on sexual function in an Italian clinical cohort of post-menopausal women. Journal of Obstetrics and Gynaecology 41:2, pages 290-297.
Read now
Read now
Rossella E. Nappi, Santiago Palacios, Nico Bruyniks, Martire Particco & Nick Panay. (2021) The European Vulvovaginal Epidemiological Survey (EVES). Impact of history of breast cancer on prevalence, symptoms, sexual function and quality of life related to vulvovaginal atrophy. Gynecological Endocrinology 37:1, pages 78-82.
Read now
Read now
R. E. Nappi, M. Kotek, A. Brešt’anský, N. Giordan & E. Tramentozzi. (2020) Effectiveness of hyaluronate-based pessaries in the treatment of vulvovaginal atrophy in postmenopausal women. Climacteric 23:5, pages 519-524.
Read now
Read now
Rossella E. Nappi, Costantino Di Carlo, Angela Maria Becorpi, Marco Gambacciani, Francesco De Seta, Raffaella Ribaldone, Chiara Benedetto & Anna Maria Paoletti. (2020) The effect of vulvovaginal atrophy on women’s quality of life from an Italian cohort of the EVES study. Journal of Obstetrics and Gynaecology 40:4, pages 512-519.
Read now
Read now
R. E. Nappi, R. Seracchioli, S. Salvatore, A. Cagnacci, T. Di Paolantonio & M. Busacca. (2019) Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES study. Gynecological Endocrinology 35:5, pages 453-459.
Read now
Read now
Gilbert G. G. Donders, Kateryna Ruban, Gert Bellen & Svitrigaile Grinceviciene. (2019) Pharmacotherapy for the treatment of vaginal atrophy. Expert Opinion on Pharmacotherapy 20:7, pages 821-835.
Read now
Read now
Andrea R. Genazzani, Ulysse Gaspard & Jean-Michel Foidart. (2019) Oral investigational drugs currently in phase I or phase II for the amelioration
of menopausal symptoms. Expert Opinion on Investigational Drugs 28:3, pages 235-247.
Read now
Read now
A. Cagnacci, A. Xholli, M. Sclauzero, M. Venier, F. Palma & M. Gambacciani. (2019) Vaginal atrophy across the menopausal age: results from the ANGEL study. Climacteric 22:1, pages 85-89.
Read now
Read now
Iuliia Naumova & Camil Castelo-Branco. (2018) Current treatment options for postmenopausal vaginal atrophy. International Journal of Women's Health 10, pages 387-395.
Read now
Read now
J. A. Simon, S. R. Davis, S. E. Althof, P. Chedraui, A. H. Clayton, S. A. Kingsberg, R. E. Nappi, S. J. Parish & W. Wolfman. (2018) Sexual well-being after menopause: An International Menopause Society White Paper. Climacteric 21:5, pages 415-427.
Read now
Read now
Articles from other publishers (28)
Kirsti ToivonenPablo Santos-IglesiasLauren M. Walker. (2021) Impact of Vulvovaginal Symptoms in Women Diagnosed with Cancer: A Psychometric Evaluation of the Day-to-Day Impact of Vaginal Aging Questionnaire. Journal of Women's Health 30:8, pages 1192-1203.
Crossref
Crossref
Paula Briggs & Dharani K Hapangama. (2021) Urogenital atrophy: The ‘unknown factors’ challenging current practice. Post Reproductive Health 27:2, pages 109-120.
Crossref
Crossref
Nikoletta Mili, Stavroula A. Paschou, Anastasia Armeni, Neoklis Georgopoulos, Dimitrios G. GoulisIrene Lambrinoudaki. (2021) Genitourinary syndrome of menopause: a systematic review on prevalence and treatment. Menopause 28:6, pages 706-716.
Crossref
Crossref
Angelica Lindén Hirschberg, Johannes Bitzer, Antonio Cano, Iuliana Ceausu, Peter Chedraui, Fatih Durmusoglu, Risto Erkkola, Dimitrios G. Goulis, Ludwig Kiesel, Patrice Lopes, Amos Pines, Mick van Trotsenburg, Irene Lambrinoudaki & Margaret Rees. (2021) Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide. Maturitas 148, pages 55-61.
Crossref
Crossref
K Mackova, AM Mazzer, MGMC Mori Da Cunha, L Hajkova Hympanova, I Urbankova, AW Kastelein, E Vodegel, K Vander Linden, H Fehervary, Z Guler, JP Roovers, L Krofta, J Verhaeghe & J Deprest. (2020) Vaginal Er:YAG laser application in the menopausal ewe model: a randomised estrogen and sham‐controlled trial. BJOG: An International Journal of Obstetrics & Gynaecology 128:6, pages 1087-1096.
Crossref
Crossref
Macrene R. Alexiades. (2020)
Fractional Co
2
Laser Treatment of the Vulva and Vagina and the Effect of Postmenopausal Duration on Efficacy
. Lasers in Surgery and Medicine 53:2, pages 185-198.
Crossref
Crossref
Michaela Gabes, Petra Stute & Christian J. Apfelbacher. (2021) Refinement of the German Day-to-Day Impact of Vaginal Aging questionnaire in perimenopausal and postmenopausal women using item response theory and classical test theory. Menopause 28:3, pages 292-299.
Crossref
Crossref
Christine M. Derzko, Sebastian Röhrich & Nick Panay. (2021) Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 μg estradiol vaginal tablets. Menopause 28:2, pages 113-118.
Crossref
Crossref
Ilnaz Zohrabi, Parvin Abedi, Somayeh Ansari, Elham Maraghi, Nader Shakiba Maram & Gholamreza Houshmand. (2020) The effect of oxytocin vaginal gel on vaginal atrophy in postmenopausal women: a randomized controlled trial. BMC Women's Health 20:1.
Crossref
Crossref
Rossella E. Nappi, Costantino Di Carlo, Laura Cucinella & Marco Gambacciani. (2020) Viewing symptoms associated with Vulvovaginal Atrophy (VVA)/Genitourinary syndrome of menopause (GSM) through the estro-androgenic lens – Cluster analysis of a web-based Italian survey among women over 40. Maturitas 140, pages 72-79.
Crossref
Crossref
Chuleekorn Sritonchai, Jittima Manonai, Areepan Sophonsritsuk & Wichai Cherdshewasart. (2020) Comparison of the effects of Pueraria mirifica gel and of placebo gel on the vaginal microenvironment of postmenopausal women with Genitourinary Syndrome of Menopause (GSM). Maturitas 140, pages 49-54.
Crossref
Crossref
Claudine Domoney, Hannah Short, Martire Particco & Nick Panay. (2020) Symptoms, attitudes and treatment perceptions of vulvo-vaginal atrophy in UK postmenopausal women: Results from the REVIVE-EU study. Post Reproductive Health 26:2, pages 101-109.
Crossref
Crossref
Nicoletta Biglia, Lino Del Pup, Riccardo Masetti, Paola Villa & Rossella E. Nappi. (2020) Vulvovaginal atrophy (VVA) in breast cancer survivors (BCS) is still an unmet medical need: results of an Italian Delphi Panel. Supportive Care in Cancer 28:6, pages 2507-2512.
Crossref
Crossref
. (2020) Safety and Feasibility of Autologous Micro-Fragmented Adipose Tissue Injections for the Treatment of Vaginal Atrophy, Vulvovaginal Dystrophy, and Stress Urinary Incontinence: An Observational Case Series. EMJ Urology.
Crossref
Crossref
Shuang You, Shuaibin Liu, Xiaojing Dong, Hu Li, Yun Zhu & Lina Hu. (2020) Intravaginal Administration of Human Type III Collagen-Derived Biomaterial with High Cell-Adhesion Activity to Treat Vaginal Atrophy in Rats. ACS Biomaterials Science & Engineering 6:4, pages 1977-1988.
Crossref
Crossref
L. Photiou, M.J. Lin, D.P. Dubin, V. Lenskaya & H. Khorasani. (2019) Review of non‐invasive vulvovaginal rejuvenation. Journal of the European Academy of Dermatology and Venereology 34:4, pages 716-726.
Crossref
Crossref
Fakhriyeh Mazalzadeh, Khadijeh Hekmat, Foroogh Namjouyan & Amal Saki. (2020) Effect of Trigonella foenum (fenugreek) vaginal cream on vaginal atrophy in postmenopausal women. Journal of Family Medicine and Primary Care 9:6, pages 2714.
Crossref
Crossref
V.E. Balan, K.V. Krasnopolskaya, M.R. Orazov, L.R. Toktar & E.V. Tikhomirova. (2020) Collagenotherapy for patients with genitourinary menopausal syndrome is a new opportunity in the doctor’s arsenal. Rossiiskii vestnik akushera-ginekologa 20:4, pages 65.
Crossref
Crossref
Angelo Cagnacci, Mario Gallo, Marco Gambacciani & Stefano Lello. (2019) Joint recommendations for the diagnosis and treatment of vulvo-vaginal atrophy in women in the peri- and post-menopausal phases from the Società Italiana per la Menopausa (SIM) and the Società Italiana della Terza Età (SIGiTE). Minerva Ginecologica 71:5.
Crossref
Crossref
Risa Kagan, Susan Kellogg-Spadt & Sharon J. Parish. (2019) Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause. Drugs & Aging 36:10, pages 897-908.
Crossref
Crossref
Maximilian Franz. (2019) Therapieoption bei vulvovaginaler Atrophie: intravaginale DHEA-Gabe. gynäkologie + geburtshilfe 24:S1, pages 20-23.
Crossref
Crossref
Stefania Alvisi, Giulia Gava, Isabella Orsili, Giulia Giacomelli, Maurizio Baldassarre, Renato Seracchioli & Maria Cristina Meriggiola. (2019) Vaginal Health in Menopausal Women. Medicina 55:10, pages 615.
Crossref
Crossref
Rossella E. Nappi, Ellis Martini, Laura Cucinella, Silvia Martella, Lara Tiranini, Alessandra Inzoli, Emanuela Brambilla, David Bosoni, Chiara Cassani & Barbara Gardella. (2019) Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women. Frontiers in Endocrinology 10.
Crossref
Crossref
Nick Panay, Santiago Palacios, Nico Bruyniks, Martire Particco & Rossella E. Nappi. (2019) Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women. Maturitas 124, pages 55-61.
Crossref
Crossref
Santiago Palacios, Silvia P. González, Micaela Fernández-Abellán, Montserrat Manubens, Pascual García-Alfaro, C.Argudo Prieto, L.Baquedano Mainar, J.Calleja Abu-Amshah, M.J.Cancelo Hidalgo, C. Castelo-Branco i Flores, P.Coronado Martin, M.Correa Rancel, M.Fernández Abellán, J.M.Fernández Moya, P.García Alfaro, M.González Fernández, S.González Rodríguez, E.Iglesias Bravo, P.Llaneza Coto, M.Manubens Grau, P.Marín Sánchez, N.Mendoza Ladrón de Guevara, B.Otero García-Ramos, S. Palacios, J.C.Presa Lorite, R.Sánchez Borrego, S.Sánchez Méndez & F.Vázquez Fernández. (2019) Impact Of Vulvovaginal Atrophy Of Menopause In Spanish Women: Prevalence And Symptoms According To The EVES Study. Sexual Medicine 7:2, pages 207-216.
Crossref
Crossref
Rossella E. Nappi, Santiago Palacios, Nico Bruyniks, Martire Particco & Nick Panay. (2019) The burden of vulvovaginal atrophy on women's daily living: implications on quality of life from a face-to-face real-life survey. Menopause 26:5, pages 485-491.
Crossref
Crossref
Santiago Palacios. 2019. Postmenopausal Diseases and Disorders. Postmenopausal Diseases and Disorders
349
366
.
Ellis Martini, Margherita Rossi, Laura Cucinella, Lara Tiranini, Silvia Martella, David Bosoni, Emanuela Brambilla, Alessandro Kunder Franco, Chiara Cassani & Rossella E. Nappi. (2018) Atrofia vulvo-vaginale (AVV): marcatore di invecchiamento femminile?. L'Endocrinologo 19:6, pages 301-306.
Crossref
Crossref